GMO International Value ETF (GMOI)

The GMO International Value ETF (ticker GMOI) is an exchange-traded fund that buys established companies in developed markets outside the United States — focusing on those exhibiting value characteristics: trading at low prices relative to earnings, cash flow, or book value. It tracks a custom index built with a disciplined mechanical process designed to capture the outperformance that historically has attached to value stocks while managing turnover and costs.

The fund operates as a pure equity holding and seeks no income or hedging — just ownership in a systematic collection of stocks. It is a flagship offering from Grantham, Mayo, & van Otterloo, the Boston-based investment firm known for systematic value approaches and for taking long-term contrarian stances on market dislocations. Unlike a simple market-cap-weighted index that treats all stocks equally (and thus tends to overweight the largest and most expensive ones), GMOI applies explicit screens and scoring to concentrate on the names most likely to deliver value over time.

The index under the hood

GMOI tracks an index composed of stocks from MSCI’s Developed Markets ex-US universe — primarily companies listed in Western Europe, Japan, Australia, Canada, and other wealthy nations, but explicitly excluding the American market. The index construction process begins with a universe of several thousand eligible securities, then applies a series of filters focused on valuation, quality, and liquidity.

The valuation screens look for companies trading at discounts across metrics such as price-to-earnings, price-to-cash-flow, and price-to-book ratios. The quality screens exclude companies with deteriorating profitability or weak balance sheets; the thinking is that a true value play is cheap for rational reasons (mean reversion and cyclicality), not because it is a deteriorating business. Liquidity filters ensure that the fund can actually trade the holdings without moving the market. The index then weights each qualifying stock according to its relative attractiveness under a composite scoring system rather than by market cap, which tilts the portfolio toward the cheapest and highest-quality names.

Twice annually the index is reconstituted and rebalanced — the fund sells winners that have appreciated away from value territory and buys fresh candidates, a mechanical discipline that forces a contrarian behavior: buy strength when it looks cheap, sell when it gets expensive.

What you actually own

The fund holds something in the range of 150 to 200 stocks, depending on index construction and market conditions. Because it operates across several developed markets, currency exposure is inherent — a shareholder receives exposure not just to stock-price movements but also to the exchange rates between those currencies and the US dollar, which can amplify or dampen returns in any given year.

The geographic breakdown skews toward Europe and Japan, where value characteristics have historically been more pronounced than in the United States, and where the pool of cheaper equities is often deeper. Holdings span sectors — industrials, financials, energy, utilities, healthcare, and cyclicals dominate the portfolio far more than in a cap-weighted index, because these are the zones where value characteristics have tended to cluster, and where disciplined rebalancing extracts most of the opportunity.

The fund is typically concentrated enough to carry meaningful single-stock risk (the largest holding might represent 2–4% of the portfolio) but diversified enough to prevent any one name from dominating volatility.

Costs and the mechanics of owning it

GMOI trades on the NASDAQ with tight spreads and reasonable volume, making it straightforward to buy or sell intraday at transparent prices. The annual expense ratio is economical by active-management standards and competitive with other factor-based ETFs; the index itself is rebalanced twice yearly, which keeps turnover moderate and tax-efficient relative to strategies that trade more frequently.

Because the fund holds non-US equities, distributions may include foreign-dividend income alongside the periodic tax distributions typical of ETFs. Shareholders receive the full tax exposure of the underlying stocks — no special tax advantage here — and the fund does not hedge currency movements.

The real risks specific to this fund

Valuation drawdowns. Value-tilted strategies have historically underperformed during long stretches when investors favor growth and momentum. A fund overweighting cheap stocks will outpace the market when sentiment rotates back toward fundamentals, but those rotations are neither guaranteed nor rapid. A holder must have conviction that the long-term value premium is real and the stomach for extended periods of lagging the overall market.

Geographic and currency concentration. Overweight exposure to Europe and Japan (and thus to the euro, yen, and sterling) introduces currency risk that a US-only investor does not face. A sharp dollar rally erodes the dollar value of foreign holdings automatically.

Liquidity and foreign-tax complexity. The smaller and cheaper companies that populate value indexes often trade in lower volume, and some face tax frictions (withholding on dividends) that cap returns compared to holding US equities.

Factor-concentration risk. By definition, a value-tilted fund is overweighting one style; it may lag dramatically during extended periods when value as a whole underperforms.

How to research the fund

Start with the fund’s prospectus and fact sheet, which lay out the index methodology, the current holdings, and the fee structure. Examine the top holdings to get a sense of the types of companies the fund favors: mature, often cyclical businesses in less-fashionable sectors. Compare the historical performance (rolling returns, not just year-to-date) to a broad developed-markets index and to peer value-focused ETFs to understand the volatility and to sense-check the approach. The fund’s annual reports explain any shifts in index construction or positioning.

A useful research question: how has the fund performed relative to developed markets outside the US during value upswings (such as 2000–2002 or 2016–2017) and during value downturns (such as 2009–2015 or 2017–2021)? That historical lens reveals whether the strategy captures the value premium or lags from timing and factor-concentration risk.